586 related articles for article (PubMed ID: 30447520)
21. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
Adjapong G; Hale M; Garrill A
Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity of analogues of antimicrobial peptides isolated from bee venoms against vulvovaginal Candida spp.
Kočendová J; Vaňková E; Volejníková A; Nešuta O; Buděšínský M; Socha O; Hájek M; Hadravová R; Čeřovský V
FEMS Yeast Res; 2019 May; 19(3):. PubMed ID: 30753486
[TBL] [Abstract][Full Text] [Related]
23. Assessment of in vitro biofilm formation by Candida species isolates from vulvovaginal candidiasis and ultrastructural characteristics.
Paiva LC; Vidigal PG; Donatti L; Svidzinski TI; Consolaro ME
Micron; 2012 Feb; 43(2-3):497-502. PubMed ID: 22001373
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
Fan SR; Liu XP; Li JW
J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
[TBL] [Abstract][Full Text] [Related]
25. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
Mushi MF; Olum R; Bongomin F
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35781514
[TBL] [Abstract][Full Text] [Related]
26. Effect of progesterone on Candida albicans biofilm formation under acidic conditions: A transcriptomic analysis.
Gonçalves B; Bernardo R; Wang C; Schröder MS; Pedro NA; Butler G; Azeredo J; Henriques M; Pereira Mira N; Silva S
Int J Med Microbiol; 2020 Apr; 310(3):151414. PubMed ID: 32173268
[TBL] [Abstract][Full Text] [Related]
27. Anti-biofilm activity of chlorhexidine digluconate against Candida albicans vaginal isolates.
Alvendal C; Mohanty S; Bohm-Starke N; Brauner A
PLoS One; 2020; 15(9):e0238428. PubMed ID: 32941438
[TBL] [Abstract][Full Text] [Related]
28. Candida and its dual lifestyle as a commensal and a pathogen.
Cauchie M; Desmet S; Lagrou K
Res Microbiol; 2017; 168(9-10):802-810. PubMed ID: 28263903
[TBL] [Abstract][Full Text] [Related]
29. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
30. Limosilactobacillus reuteri 29A Cell-Free Supernatant Antibiofilm and Antagonistic Effects in Murine Model of Vulvovaginal Candidiasis.
Boahen A; Chew SY; Neela VK; Than LTL
Probiotics Antimicrob Proteins; 2023 Dec; 15(6):1681-1699. PubMed ID: 36881331
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effects of vaginal
Takano T; Kudo H; Eguchi S; Matsumoto A; Oka K; Yamasaki Y; Takahashi M; Koshikawa T; Takemura H; Yamagishi Y; Mikamo H; Kunishima H
Front Cell Infect Microbiol; 2023; 13():1113401. PubMed ID: 37201113
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia.
Venugopal D; Husain K; Mustafa SA; Sabeen S
J Mycol Med; 2021 Jun; 31(2):101049. PubMed ID: 33153879
[TBL] [Abstract][Full Text] [Related]
33. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
Chen Z; Jin J; Chen H; Chen Y; Feng S
Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
[TBL] [Abstract][Full Text] [Related]
34. Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression.
Zhang JY; Liu JH; Liu FD; Xia YH; Wang J; Liu X; Zhang ZQ; Zhu N; Yan-Yan ; Ying Y; Huang XT
Mycoses; 2014 Oct; 57(10):584-91. PubMed ID: 24962255
[TBL] [Abstract][Full Text] [Related]
35. Species spectrum and antifungal susceptibility profile of vaginal isolates of Candida in Kuwait.
Alfouzan W; Dhar R; Ashkanani H; Gupta M; Rachel C; Khan ZU
J Mycol Med; 2015 Mar; 25(1):23-8. PubMed ID: 25534676
[TBL] [Abstract][Full Text] [Related]
36. ROS mediated anticandidal efficacy of 3-Bromopyruvate prevents vulvovaginal candidiasis in mice model.
Jothi R; Hong ST; Enkhtsatsral M; Pandian SK; Gowrishankar S
PLoS One; 2023; 18(12):e0295922. PubMed ID: 38153954
[TBL] [Abstract][Full Text] [Related]
37. Vulvovaginal candidiasis in a Flemish patient population.
De Vos MM; Cuenca-Estrella M; Boekhout T; Theelen B; Matthijs N; Bauters T; Nailis H; Dhont MA; Rodriguez-Tudela JL; Nelis HJ
Clin Microbiol Infect; 2005 Dec; 11(12):1005-11. PubMed ID: 16307555
[TBL] [Abstract][Full Text] [Related]
38. Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis.
Zhu YX; Shi Y; Fan SR; Liu XP; Yang J; Zhong SL
BMC Infect Dis; 2019 May; 19(1):461. PubMed ID: 31117966
[TBL] [Abstract][Full Text] [Related]
39. Changing virulence factors among vaginal non-
Kalaiarasan K; Singh R; Chaturvedula L
Indian J Med Microbiol; 2018; 36(3):364-368. PubMed ID: 30429388
[TBL] [Abstract][Full Text] [Related]
40. Differential Response of
Salama OE; Gerstein AC
Antimicrob Agents Chemother; 2022 May; 66(5):e0240621. PubMed ID: 35446135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
